Literature DB >> 31967058

A RARE CASE OF ACROMEGALY AND AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: CASE REPORT AND BRIEF REVIEW OF LITERATURE.

Swayamsidha Mangaraj, Debasish Patro, Arun Kumar Choudhury, Anoj Kumar Baliarsinha.   

Abstract

OBJECTIVE: Acromegaly is a classic endocrine disorder caused by a growth hormone (GH)-secreting pituitary adenoma in an overwhelming majority of patients. The diagnosis may be delayed by several years due to the slow growing and insidious nature of the disease. Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disorder characterized by multiple renal cysts and various other systemic manifestations. The purpose of this article is to report a rare case of acromegaly with coexistent ADPKD.
METHODS: We report a case of 42-year-old female with acromegaly and ADPKD along with a brief review of literature.
RESULTS: The patient was referred to us for evaluation of progressive acral enlargement and coarsening of facial features. Endocrine evaluation confirmed the diagnosis of acromegaly due to an underlying GH-secreting pituitary macroadenoma. She was also found to have ADPKD. We discuss the clinical features and management of the patient.
CONCLUSION: The association of pituitary adenomas and ADPKD is very rare and interesting. All affected individuals with pituitary adenomas and ADPKD in the literature are women. Furthermore, all reported pituitary adenomas in these individuals (including ours) are functional GH-secreting ones. These findings argue against a mere chance association between the two diseases.
Copyright © 2019 AACE.

Entities:  

Year:  2019        PMID: 31967058      PMCID: PMC6876956          DOI: 10.4158/ACCR-2019-0128

Source DB:  PubMed          Journal:  AACE Clin Case Rep        ISSN: 2376-0605


  19 in total

1.  Somatostatin analog therapy for severe polycystic liver disease: results after 2 years.

Authors:  Marie C Hogan; Tetyana V Masyuk; Linda Page; David R Holmes; Xujian Li; Eric J Bergstralh; Maria V Irazabal; Bohyun Kim; Bernard F King; James F Glockner; Nicholas F Larusso; Vicente E Torres
Journal:  Nephrol Dial Transplant       Date:  2012-07-06       Impact factor: 5.992

Review 2.  Autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris; Yves Pirson
Journal:  Lancet       Date:  2007-04-14       Impact factor: 79.321

3.  Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system.

Authors:  E Parker; L J Newby; C C Sharpe; S Rossetti; A J Streets; P C Harris; M J O'Hare; A C M Ong
Journal:  Kidney Int       Date:  2007-03-28       Impact factor: 10.612

4.  Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease.

Authors:  Marusia Lilova; Bernard S Kaplan; Kevin E C Meyers
Journal:  Pediatr Nephrol       Date:  2002-11-26       Impact factor: 3.714

5.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

6.  Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.

Authors:  Arlene B Chapman; James E Bost; Vicente E Torres; Lisa Guay-Woodford; Kyongtae Ty Bae; Douglas Landsittel; Jie Li; Bernard F King; Diego Martin; Louis H Wetzel; Mark E Lockhart; Peter C Harris; Marva Moxey-Mims; Mike Flessner; William M Bennett; Jared J Grantham
Journal:  Clin J Am Soc Nephrol       Date:  2012-02-16       Impact factor: 8.237

7.  Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation.

Authors:  Luis V Syro; Jamie L Sundsbak; Bernd W Scheithauer; Rodrigo A Toledo; Mauricio Camargo; Christina M Heyer; Tomoko Sekiya; Humberto Uribe; Jorge I Escobar; Martin Vasquez; Fabio Rotondo; Sergio P A Toledo; Kalman Kovacs; Eva Horvath; Dusica Babovic-Vuksanovic; Peter C Harris
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

8.  Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide.

Authors:  Anna Caroli; Luca Antiga; Mariateresa Cafaro; Giorgio Fasolini; Andrea Remuzzi; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 8.237

9.  [Hypophyseal incidentaloma in a patient with autosomal dominant polycystic kidney disease].

Authors:  R Fajfr; B Müller; P Diem
Journal:  Praxis (Bern 1994)       Date:  2002-06-19

Review 10.  Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.

Authors:  Tevfik Ecder; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.